• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13D/A filed by Diversified Healthcare Trust (Amendment)

    10/5/23 4:31:22 PM ET
    $DHC
    Real Estate Investment Trusts
    Real Estate
    Get the next $DHC alert in real time by email
    SC 13D/A 1 p23-2547sc13da.htm DIVERSIFIED HEALTHCARE TRUST
    SECURITIES AND EXCHANGE COMMISSION  
       
    Washington, D.C. 20549  
       
    SCHEDULE 13D/A

    (Amendment No. 2)

     

    INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
    TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO
    RULE 13d-2(a)
     
    Under the Securities Exchange Act of 1934
     
     

    Diversified Healthcare Trust

    (Name of Issuer)
     

    Common Shares of Beneficial Interest, par value $0.01 per share

    (Title of Class of Securities)
     

    25525P107

    (CUSIP Number)
     

    D. E. Shaw & Co., L.P.

    Attn: Legal & Compliance Department

    1166 Avenue of the Americas, 9th Floor
    New York, New York 10036

    (212) 478-0000

    Copies to:

    Eleazer Klein, Esq.

    Adriana Schwartz, Esq.

    919 Third Avenue

    New York, New York 10022

    (212) 756-2000

    (Name, Address and Telephone Number of Person
    Authorized to Receive Notices and Communications)
     

    September 29, 2023

    (Date of Event which Requires Filing of this Schedule)
     

    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. [ ]

     

    NOTE: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See § 240.13d-7 for other parties to whom copies are to be sent.

    -----------------------------


    * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

    CUSIP No. 25525P107SCHEDULE 13D/APage 2 of 11 Pages

     

    1

    NAME OF REPORTING PERSON

    D. E. SHAW GALVANIC PORTFOLIOS, L.L.C.

    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) ¨

    (b) ¨

    3 SEC USE ONLY
    4

    SOURCE OF FUNDS

    WC

    5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) ¨
    6

    CITIZENSHIP OR PLACE OF ORGANIZATION

    Delaware

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH
    7

    SOLE VOTING POWER

    0

    8

    SHARED VOTING POWER

    13,768,926

    9

    SOLE DISPOSITIVE POWER

    0

    10

    SHARED DISPOSITIVE POWER

    13,768,926

    11

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH PERSON

    13,768,926

    12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES ¨
    13

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) (see Item 5)

    5.7%

    14

    TYPE OF REPORTING PERSON

    OO

             

     

     

     

     

     

    CUSIP No. 25525P107SCHEDULE 13D/APage 3 of 11 Pages

     

    1

    NAME OF REPORTING PERSON

    D. E. SHAW MANAGER II, L.L.C.

    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) ¨

    (b) ¨

    3 SEC USE ONLY
    4

    SOURCE OF FUNDS

    AF

    5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) ¨
    6

    CITIZENSHIP OR PLACE OF ORGANIZATION

    Delaware

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH
    7

    SOLE VOTING POWER

    0

    8

    SHARED VOTING POWER

    13,768,926

    9

    SOLE DISPOSITIVE POWER

    0

    10

    SHARED DISPOSITIVE POWER

    13,768,926

    11

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH PERSON

    13,768,926

    12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES ¨
    13

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) (see Item 5)

    5.7%

    14

    TYPE OF REPORTING PERSON

    OO

             

     

     

     

     

     

    CUSIP No. 25525P107SCHEDULE 13D/APage 4 of 11 Pages

     

    1

    NAME OF REPORTING PERSON

    D. E. SHAW ADVISER II, L.L.C.

    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) ¨

    (b) ¨

    3 SEC USE ONLY
    4

    SOURCE OF FUNDS

    AF

    5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) ¨
    6

    CITIZENSHIP OR PLACE OF ORGANIZATION

    Delaware

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH
    7

    SOLE VOTING POWER

    0

    8

    SHARED VOTING POWER

    13,768,926

    9

    SOLE DISPOSITIVE POWER

    0

    10

    SHARED DISPOSITIVE POWER

    13,768,926

    11

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH PERSON

    13,768,926

    12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES ¨
    13

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) (see Item 5)

    5.7%

    14

    TYPE OF REPORTING PERSON

    IA

             

     

     

     

     

    CUSIP No. 25525P107SCHEDULE 13D/APage 5 of 11 Pages

     

    1

    NAME OF REPORTING PERSON

    D. E. SHAW & CO., L.L.C.

    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) ¨

    (b) ¨

    3 SEC USE ONLY
    4

    SOURCE OF FUNDS

    AF

    5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) ¨
    6

    CITIZENSHIP OR PLACE OF ORGANIZATION

    Delaware

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH
    7

    SOLE VOTING POWER

    0

    8

    SHARED VOTING POWER

    13,768,926

    9

    SOLE DISPOSITIVE POWER

    0

    10

    SHARED DISPOSITIVE POWER

    13,768,926

    11

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH PERSON

    13,768,926

    12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES ¨
    13

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) (see Item 5)

    5.7%

    14

    TYPE OF REPORTING PERSON

    OO

             

     

     

     

     

    CUSIP No. 25525P107SCHEDULE 13D/APage 6 of 11 Pages

     

    1

    NAME OF REPORTING PERSON

    D. E. SHAW & CO., L.P.

    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) ¨

    (b) ¨

    3 SEC USE ONLY
    4

    SOURCE OF FUNDS

    AF

    5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) x
    6

    CITIZENSHIP OR PLACE OF ORGANIZATION

    Delaware

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH
    7

    SOLE VOTING POWER

    0

    8

    SHARED VOTING POWER

    13,768,926

    9

    SOLE DISPOSITIVE POWER

    0

    10

    SHARED DISPOSITIVE POWER

    13,768,926

    11

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH PERSON

    13,768,926

    12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES ¨
    13

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) (see Item 5)

    5.7%

    14

    TYPE OF REPORTING PERSON

    IA, PN

             

     

     

     

     

    CUSIP No. 25525P107SCHEDULE 13D/APage 7 of 11 Pages

     

    1

    NAME OF REPORTING PERSON

    DAVID E. SHAW

    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) ¨

    (b) ¨

    3 SEC USE ONLY
    4

    SOURCE OF FUNDS

    AF

    5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) ¨
    6

    CITIZENSHIP OR PLACE OF ORGANIZATION

    United States

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH
    7

    SOLE VOTING POWER

    0

    8

    SHARED VOTING POWER

    13,768,926

    9

    SOLE DISPOSITIVE POWER

    0

    10

    SHARED DISPOSITIVE POWER

    13,768,926

    11

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH PERSON

    13,768,926

    12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES ¨
    13

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) (see Item 5)

    5.7%

    14

    TYPE OF REPORTING PERSON

    IN

             

     

     

     

     

    CUSIP No. 25525P107SCHEDULE 13D/APage 8 of 11 Pages

    Introductory Note

    This Amendment No. 2 to Schedule 13D is filed by and on behalf of each of the Reporting Persons to amend and supplement the Schedule 13D related to the Common Shares of Beneficial Interest, par value $0.01 per share (the “Shares”), of Diversified Healthcare Trust, a Maryland real estate investment trust (the “Issuer”), previously filed by the Reporting Persons with the Securities and Exchange Commission (the “SEC”) on June 12, 2023, as amended and supplemented by Amendment No. 1 to Schedule 13D filed on July 18, 2023 (as amended, the “Schedule 13D”). Each capitalized term used and not defined herein shall have the meaning assigned to such term in the Schedule 13D. Except as provided herein, each Item of the Schedule 13D remains unchanged.

    Item 2. IDENTITY AND BACKGROUND

     

    Item 2(d), (e) of the Schedule 13D is hereby amended and restated as follows:

    (d) During the last five years, neither any Reporting Person nor, to the best knowledge of any Reporting Person, any person named in this Item 2, has been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).

    (e) On September 29, 2023, the SEC issued a settled order finding that language in certain employment-related agreements used by DESCO LP raised impediments to employees’ participation in the SEC’s whistleblower program in violation of Exchange Act Rule 21F-17(a). In the order, DESCO LP, without admitting or denying the findings, agreed to a censure, to cease-and-desist from committing or causing any violations and any future violations of Rule 21F-17(a), and to pay a $10 million penalty. The SEC’s order acknowledged that DESCO LP took a number of steps dating back to 2017 to affirm employees’ whistleblowing rights, including by sending a firmwide email emphasizing those rights and adding specific whistleblower protection language to the firm’s policy materials; however, similar whistleblower protection language was not included directly in DESCO LP’s employment agreements until April 2019 or in its form of separation release until June 2023. DESCO LP remediated the relevant language in all applicable employment-related agreements prior to the issuance of the SEC’s order. Except with respect to the matter described above, no Reporting Person has, during the last five years, been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding has been or is subject to a judgement, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.

    Item 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION.

     

    Item 3 of the Schedule 13D is hereby amended and restated as follows:

    In acquiring 13,768,926 Shares, Galvanic Portfolios expended approximately $11,215,376 (excluding commissions) of its working capital.

    Item 5. INTEREST IN SECURITIES OF THE ISSUER.

     

    Item 5(a), (b) of the Schedule 13D is hereby amended and restated as follows:

     

    (a), (b) Based upon the Issuer’s Form 10-Q filed with the SEC on August 1, 2023, there were 239,786,763 Shares issued and outstanding of the Issuer as of July 27, 2023. The 13,768,926 Shares beneficially owned by Galvanic Portfolios (the “Subject Shares”) represent approximately 5.7% of the Shares issued and outstanding.

     

     

    CUSIP No. 25525P107SCHEDULE 13D/APage 9 of 11 Pages

    Manager II, as the manager of Galvanic Portfolios, may be deemed to have the shared power to vote or direct the vote of (and the shared power to dispose or direct the disposition of) the Subject Shares. Adviser II, as the investment adviser of Galvanic Portfolios, may be deemed to have the shared power to vote or direct the vote of (and the shared power to dispose or direct the disposition of) the Subject Shares. DESCO LLC, as the managing member of Manager II, may be deemed to have the shared power to vote or direct the vote of (and the shared power to dispose or direct the disposition of) the Subject Shares. DESCO LP, as the managing member of Adviser II, may be deemed to have the shared power to vote or direct the vote of (and the shared power to dispose or direct the disposition of) the Subject Shares. On October 5, 2023, the Reporting Persons beneficially owned 5.7% of the Shares issued and outstanding. None of Manager II, Adviser II, DESCO LLC, or DESCO LP owns any of the Subject Shares directly, and each of Manager II, Adviser II, DESCO LLC, and DESCO LP disclaims beneficial ownership of the Subject Shares.

    David E. Shaw does not own any shares directly. By virtue of David E. Shaw’s position as President and sole shareholder of DESCO Inc., which is the general partner of DESCO LP, which in turn is the managing member of Adviser II, which in turn is the investment adviser of Galvanic Portfolios, and by virtue of David E. Shaw’s position as President and sole shareholder of DESCO II Inc., which is the managing member of DESCO LLC, which in turn is the managing member of Manager II, which in turn is the manager of Galvanic Portfolios, David E. Shaw may be deemed to have the shared power to vote or direct the vote of, and the shared power to dispose or direct the disposition of, the Subject Shares as described above. Therefore, David E. Shaw may be deemed to be the beneficial owner of the Subject Shares. David E. Shaw disclaims beneficial ownership of the Subject Shares.

    As of October 5, 2023, neither any Reporting Person nor, to the best knowledge of any Reporting Person, any of the persons set forth in Item 2, owned any Shares other than those set forth in Item 5.

    Item 5(c) of the Schedule 13D is hereby amended and supplemented as follows:

    (c) The trading dates, number of Shares purchased or sold, and the price per Share for all transactions by the Reporting Persons in the Shares from August 6, 2023 through October 5, 2023, which were all brokered transactions, are set forth below:

      Name Date Price per Share1 Number of Shares
    Purchased/(Sold)
     
      Galvanic Portfolios 08/07/2023 $3.00212 (8,100)  
      Galvanic Portfolios 08/08/2023 $3.16173 (347,744)  
      Galvanic Portfolios 08/09/2023 $3.05034 (65,137)  
      Galvanic Portfolios 08/10/2023 $3.09085 (135,356)  
      Galvanic Portfolios 10/03/2023 $1.80476 162,000  
      Galvanic Portfolios 10/04/2023 $1.86477 148,000  
      Galvanic Portfolios 10/05/2023 $1.88448 3,700  

     

    Item 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT TO SECURITIES OF THE ISSUER.

     

    The first paragraph of Item 6 of the Schedule 13D is hereby amended and restated as follows:

     

    Galvanic Portfolios holds an aggregate principal amount of $30,750,000 of the Issuer’s 5.625% Senior Notes due 2042, $20,130,000 of the Issuer’s 4.75% Senior Notes due 2024, and $16,996,000 of the Issuer’s 9.75% Senior Notes due 2025 (collectively, the “Bonds”). These Bonds do not give the Reporting Persons direct or indirect voting, investment, or dispositive control over any securities of the Issuer. Accordingly, the Reporting Persons disclaim any beneficial ownership in any securities that may be referenced in such Bonds.

     

    ________________________

    1 Where weighted average price is used for the reported transactions, the Reporting Persons undertake to provide upon request by the SEC, full information regarding the number of shares purchased or sold at each separate price.

    2 A weighted average price based on prices ranging from $3.0000 to $3.0100.

    3 A weighted average price based on prices ranging from $3.0100 to $3.2900.

    4 A weighted average price based on prices ranging from $3.0000 to $3.2100.

    5 A weighted average price based on prices ranging from $3.0000 to $3.1400.

    6 A weighted average price based on prices ranging from $1.7700 to $1.8162.

    7 A weighted average price based on prices ranging from $1.7800 to $1.8950.

    8 A weighted average price based on prices ranging from $1.8500 to $1.9123.

     

     

    CUSIP No. 25525P107SCHEDULE 13D/APage 10 of 11 Pages

     

     

    Item 7.

    MATERIAL TO BE FILED AS EXHIBITS.

     

    Exhibit 1: Joint Filing Agreement, by and among the Reporting Persons, dated June 12, 2023 (incorporated by reference to the Schedule 13D filed on June 12, 2023).
    Exhibit 2: Power of Attorney, granted by David E. Shaw relating to D. E. Shaw & Co., Inc., in favor of the signatories hereto, among others, dated March 1, 2017.
    Exhibit 3: Power of Attorney, granted by David E. Shaw relating to D. E. Shaw & Co. II, Inc., in favor of the signatories hereto, among others, dated March 1, 2017.
    Exhibit 4: Presentation (incorporated herein by reference to the Form PX14A6G filed by certain of the Reporting Persons with the SEC on July 14, 2023).

     

     

     

     

     

    CUSIP No. 25525P107SCHEDULE 13D/APage 11 of 11 Pages

     

    SIGNATURES

    After reasonable inquiry and to the best of each of the undersigned’s knowledge and belief, each of the undersigned, severally and not jointly, certifies that the information set forth in this statement is true, complete and correct. Powers of Attorney, dated March 1, 2017, granted by David E. Shaw in favor of Nathan Thomas, are attached hereto as Exhibits 2 and 3 and incorporated herein by reference.

    Dated: October 5, 2023

     

      D. E. Shaw Galvanic Portfolios, L.L.C.
         
      By: /s/ Nathan Thomas
        Nathan Thomas
        Authorized Signatory
       
      D. E. Shaw Manager II, L.L.C.
       
      By: /s/ Nathan Thomas
        Nathan Thomas
        Authorized Signatory
       
      D. E. Shaw Adviser II, L.L.C.
       
      By: /s/ Nathan Thomas
        Nathan Thomas
        Chief Compliance Officer
       
      D. E. Shaw & Co., L.L.C.
         
      By: /s/ Nathan Thomas
        Nathan Thomas
        Authorized Signatory
         
      D. E. Shaw & Co., L.P.
         
      By: /s/ Nathan Thomas
        Nathan Thomas
        Chief Compliance Officer
         
      David E. Shaw
         
      By: /s/ Nathan Thomas
        Nathan Thomas
        Attorney-in-Fact for David E. Shaw

     

     

     
     

    Exhibit 2

     

    POWER OF ATTORNEY

    FOR CERTAIN REGULATORY FILINGS

    INCLUDING CERTAIN FILINGS

    UNDER THE SECURITIES EXCHANGE ACT OF 1934

    AND THE INVESTMENT ADVISERS ACT OF 1940

     

     

    I, David E. Shaw, hereby make, constitute, and appoint each of:

     

    Edward Fishman,

     

    Julius Gaudio,

     

    Martin Lebwohl,

     

    Maximilian Stone,

     

    David Sweet,

     

    Nathan Thomas, and

     

    Eric Wepsic,

     

    acting individually, as my agent and attorney-in-fact, with full power of substitution, for the purpose of, from time to time, (i) executing in my name and/or my capacity as President of D. E. Shaw & Co., Inc. (acting for itself or as the general partner of D. E. Shaw & Co., L.P. and general partner, managing member, or manager of other entities, any of which in turn may be acting for itself or other entities) all documents, certificates, instruments, statements, other filings, and amendments to the foregoing (collectively, “documents”) determined by such person to be necessary or appropriate to comply with any registration or regulatory disclosure requirements and/or ownership or control-person reporting requirements imposed by any United States or non-United States governmental or regulatory authority, including without limitation Form ADV, Forms 3, 4, 5, and 13F, and Schedules 13D and 13G required to be filed with the United States Securities and Exchange Commission, and (ii) delivering, furnishing, or filing any such documents to or with the appropriate governmental or regulatory authority. Any such determination shall be conclusively evidenced by such person’s execution, delivery, furnishing, and/or filing of the applicable document.

     

    This power of attorney shall be valid from the date hereof and replaces the power granted on January 1, 2017, which is hereby cancelled.

     

    IN WITNESS HEREOF, I have executed this instrument as of the date set forth below.

     

    Date: March 1, 2017

     

    DAVID E. SHAW, as President of

    D. E. Shaw & Co., Inc.

    /s/ David E. Shaw

    New York, New York

     

     
     

    Exhibit 3

     

    POWER OF ATTORNEY

    FOR CERTAIN REGULATORY FILINGS

    INCLUDING CERTAIN FILINGS

    UNDER THE SECURITIES EXCHANGE ACT OF 1934

    AND THE INVESTMENT ADVISERS ACT OF 1940

     

     

    I, David E. Shaw, hereby make, constitute, and appoint each of:

     

    Edward Fishman,

     

    Julius Gaudio,

     

    Martin Lebwohl,

     

    Maximilian Stone,

     

    David Sweet,

     

    Nathan Thomas, and

     

    Eric Wepsic,

     

    acting individually, as my agent and attorney-in-fact, with full power of substitution, for the purpose of, from time to time, (i) executing in my name and/or my capacity as President of D. E. Shaw & Co. II, Inc. (acting for itself or as the managing member of D. E. Shaw & Co., L.L.C. and general partner, managing member, or manager of other entities, any of which in turn may be acting for itself or other entities) all documents, certificates, instruments, statements, other filings, and amendments to the foregoing (collectively, “documents”) determined by such person to be necessary or appropriate to comply with any registration or regulatory disclosure requirements and/or ownership or control-person reporting requirements imposed by any United States or non-United States governmental or regulatory authority, including without limitation Form ADV, Forms 3, 4, 5, and 13F, and Schedules 13D and 13G required to be filed with the United States Securities and Exchange Commission, and (ii) delivering, furnishing, or filing any such documents to or with the appropriate governmental or regulatory authority. Any such determination shall be conclusively evidenced by such person’s execution, delivery, furnishing, and/or filing of the applicable document.

     

    This power of attorney shall be valid from the date hereof and replaces the power granted on January 1, 2017, which is hereby cancelled.

     

    IN WITNESS HEREOF, I have executed this instrument as of the date set forth below.

     

    Date: March 1, 2017

     

    DAVID E. SHAW, as President of

    D. E. Shaw & Co. II, Inc.

    /s/ David E. Shaw

    New York, New York

     

    Get the next $DHC alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $DHC

    DatePrice TargetRatingAnalyst
    4/3/2025$4.50Buy
    B. Riley Securities
    12/30/2021$5.00 → $6.00Buy
    B. Riley Securities
    7/29/2021$5.00 → $4.75Equal-Weight
    Morgan Stanley
    More analyst ratings

    $DHC
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Diversified Healthcare Trust Closes a New $150 Million Secured Revolving Credit Facility

      Transaction Further Enhances DHC's Liquidity and Leverages Attractive SHOP Assets Diversified Healthcare Trust (NASDAQ:DHC) today announced the closing of a new $150 million secured revolving credit facility. The facility is secured by 14 senior housing communities with 2,632 living units managed by Five Star Senior Living, the operating division of AlerisLife Inc., and provides DHC with enhanced liquidity to support its general business needs. The revolving credit facility has an initial term of four years, with two six-month extension options, subject to certain conditions, and bears interest at a rate equal to SOFR plus a spread of 250 to 300 basis points, depending on DHC's net leve

      6/12/25 8:00:00 AM ET
      $DHC
      $RMR
      Real Estate Investment Trusts
      Real Estate
      Professional Services
      Consumer Discretionary
    • Diversified Healthcare Trust Closes $94 Million of Mortgage Financings Secured by Six SHOP Communities

      Financing Proceeds and Cash on Hand Will Repay in Full the Remaining Outstanding June 2025 Senior Notes Diversified Healthcare Trust (NASDAQ:DHC) today announced that it has closed two fixed rate mortgage financings totaling $94.3 million, secured by six senior housing communities managed by Five Star Senior Living, the operating division of AlerisLife Inc. The financings consist of a $64.0 million five-year mortgage loan and a $30.3 million ten-year Fannie Mae mortgage loan. Proceeds from these loans, together with cash on hand, will be used to repay the remaining $100.0 million of DHC's 9.75% senior notes due June 2025. The $64.0 million loan bears a fixed interest rate of 6.57% and i

      6/2/25 8:00:00 AM ET
      $DHC
      $RMR
      Real Estate Investment Trusts
      Real Estate
      Professional Services
      Consumer Discretionary
    • Diversified Healthcare Trust to Present at Nareit's REITweek 2025 Investor Conference on Tuesday, June 3rd

      Diversified Healthcare Trust (NASDAQ:DHC) today announced that President and Chief Executive Officer Chris Bilotto and Chief Financial Officer and Treasurer Matthew Brown will be presenting at Nareit's REITweek 2025 Investor Conference in New York, NY on Tuesday, June 3, 2025 at 1:45 p.m. Eastern Time. A live audio webcast of the presentation will be available in a listen-only mode on the company's website at https://www.dhcreit.com/investors/events-and-presentations/default.aspx. Participants wanting to access the webcast should visit the company's website about 15 minutes before the start of the presentation. About Diversified Healthcare Trust DHC is a real estate investment trust focu

      5/20/25 8:00:00 AM ET
      $DHC
      $RMR
      Real Estate Investment Trusts
      Real Estate
      Professional Services
      Consumer Discretionary

    $DHC
    Leadership Updates

    Live Leadership Updates

    See more
    • Seven Hills Realty Trust Appoints Matthew Brown as Chief Financial Officer and Treasurer

      Seven Hills Realty Trust (NASDAQ:SEVN) today announced that Matthew Brown has been appointed as Chief Financial Officer and Treasurer, effective March 10, 2025. Mr. Brown is a Senior Vice President of The RMR Group (NASDAQ:RMR) where he oversees the accounting and finance functions and the tax department. Mr. Brown has served in various accounting and finance leadership roles since joining RMR in 2007 and has extensive experience in reporting and compliance, mergers and acquisitions, capital market transactions and technical accounting matters. Mr. Brown is a certified public accountant and also serves as Chief Financial Officer of Diversified Healthcare Trust (NASDAQ:DHC). Mr. Brown succ

      3/10/25 8:00:00 AM ET
      $DHC
      $RMR
      $SEVN
      Real Estate Investment Trusts
      Real Estate
      Professional Services
      Consumer Discretionary
    • Service Properties Trust Appoints Chris Bilotto as a Managing Trustee, President and Chief Executive Officer

      Service Properties Trust (NASDAQ:SVC) today announced that Chris Bilotto has been appointed as a Managing Trustee, President and Chief Executive Officer of SVC, effective March 10, 2025. Mr. Bilotto is an Executive Vice President of The RMR Group (NASDAQ:RMR), overseeing its acquisition platform, asset management for all hotel and senior living properties, as well as property development and redevelopment throughout the United States. Prior to joining RMR in 2011, Mr. Bilotto worked at General Growth Properties in various management roles. Mr. Bilotto also serves as a Managing Trustee, President and Chief Executive Officer of Diversified Healthcare Trust (NASDAQ:DHC). Mr. Bilotto succeeds

      3/10/25 8:00:00 AM ET
      $DHC
      $RMR
      $SVC
      Real Estate Investment Trusts
      Real Estate
      Professional Services
      Consumer Discretionary
    • Diversified Healthcare Trust Appoints Anthony Paula as Vice President

      Diversified Healthcare Trust (NASDAQ:DHC) today announced that Anthony Paula has been appointed Vice President. Mr. Paula is a Vice President of The RMR Group (NASDAQ:RMR), whose responsibilities include overseeing the accounting, SEC reporting and corporate finance functions for DHC. Mr. Paula has more than 15 years of real estate experience, including accounting and corporate finance, capital market transactions, SEC reporting and compliance. Prior to joining RMR in 2011, Mr. Paula worked at a public accounting firm as a staff accountant. About Diversified Healthcare Trust DHC is a real estate investment trust focused on owning high-quality healthcare properties located throughout t

      12/18/24 4:15:00 PM ET
      $DHC
      $RMR
      Real Estate Investment Trusts
      Real Estate
      Professional Services
      Consumer Discretionary

    $DHC
    Financials

    Live finance-specific insights

    See more
    • Diversified Healthcare Trust Announces First Quarter 2025 Results

      Diversified Healthcare Trust (NASDAQ:DHC) today announced its financial results for the quarter ended March 31, 2025, which can be found at the Quarterly Reports section of DHC's website at https://www.dhcreit.com/investors/financial-information/quarterly/default.aspx. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250505442615/en/ A conference call to discuss DHC's first quarter 2025 financial results will be held on Tuesday, May 6, 2025 at 10:00 a.m. Eastern Time. The conference call may be accessed by dialing (877) 329-4297 or (412) 317-5435 (if calling from outside the United States and Canada); a pass code is not required. A

      5/5/25 4:15:00 PM ET
      $DHC
      $RMR
      Real Estate Investment Trusts
      Real Estate
      Professional Services
      Consumer Discretionary
    • Diversified Healthcare Trust Announces Quarterly Dividend on Common Shares

      Diversified Healthcare Trust (NASDAQ:DHC) today announced a regular quarterly cash distribution on its common shares of $0.01 per share ($0.04 per share per year). This distribution will be paid to DHC's common shareholders of record as of the close of business on April 22, 2025 and distributed on or about May 15, 2025. About Diversified Healthcare Trust: DHC is a real estate investment trust focused on owning high-quality healthcare properties located throughout the United States. DHC seeks diversification across the health services spectrum by care delivery and practice type, by scientific research disciplines and by property type and location. As of December 31, 2024, DHC's approximate

      4/10/25 4:30:00 PM ET
      $DHC
      $RMR
      Real Estate Investment Trusts
      Real Estate
      Professional Services
      Consumer Discretionary
    • Diversified Healthcare Trust First Quarter 2025 Conference Call Scheduled for Tuesday, May 6th

      Diversified Healthcare Trust (NASDAQ:DHC) today announced that it will issue a press release containing its first quarter 2025 financial results after the Nasdaq closes on Monday, May 5, 2025. On Tuesday, May 6, 2025 at 10:00 a.m. Eastern Time, President and Chief Executive Officer Christopher Bilotto, Chief Financial Officer and Treasurer Matthew Brown and Vice President Anthony Paula will host a conference call to discuss these results. The conference call telephone number is (877) 329-4297. Participants calling from outside the United States and Canada should dial (412) 317-5435. No pass code is necessary to access the call from either number. Participants should dial in about 15 minute

      4/7/25 4:15:00 PM ET
      $DHC
      $RMR
      Real Estate Investment Trusts
      Real Estate
      Professional Services
      Consumer Discretionary

    $DHC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Felder Alan L. was granted 29,141 units of Common Shares of Beneficial Interest, increasing direct ownership by 87% to 62,723 units (SEC Form 4)

      4 - DIVERSIFIED HEALTHCARE TRUST (0001075415) (Issuer)

      6/2/25 4:49:00 PM ET
      $DHC
      Real Estate Investment Trusts
      Real Estate
    • Director Hollis Phyllis M. was granted 29,141 units of Common Shares of Beneficial Interest, increasing direct ownership by 50% to 87,080 units (SEC Form 4)

      4 - DIVERSIFIED HEALTHCARE TRUST (0001075415) (Issuer)

      6/2/25 4:47:40 PM ET
      $DHC
      Real Estate Investment Trusts
      Real Estate
    • Director Neher Dawn K. was granted 29,141 units of Common Shares of Beneficial Interest, increasing direct ownership by 79% to 66,178 units (SEC Form 4)

      4 - DIVERSIFIED HEALTHCARE TRUST (0001075415) (Issuer)

      6/2/25 4:46:13 PM ET
      $DHC
      Real Estate Investment Trusts
      Real Estate

    $DHC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • B. Riley Securities resumed coverage on Diversified Healthcare Trust with a new price target

      B. Riley Securities resumed coverage of Diversified Healthcare Trust with a rating of Buy and set a new price target of $4.50

      4/3/25 8:18:01 AM ET
      $DHC
      Real Estate Investment Trusts
      Real Estate
    • B. Riley Securities reiterated coverage on Diversified Healthcare with a new price target

      B. Riley Securities reiterated coverage of Diversified Healthcare with a rating of Buy and set a new price target of $6.00 from $5.00 previously

      12/30/21 8:36:39 AM ET
      $DHC
      Real Estate Investment Trusts
      Real Estate
    • Morgan Stanley reiterated coverage on Diversified Healthcare with a new price target

      Morgan Stanley reiterated coverage of Diversified Healthcare with a rating of Equal-Weight and set a new price target of $4.75 from $5.00 previously

      7/29/21 8:42:10 AM ET
      $DHC
      Real Estate Investment Trusts
      Real Estate

    $DHC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • CFO and Treasurer Brown Matthew C. bought $5,098 worth of Common Shares of Beneficial Interest (2,000 units at $2.55), increasing direct ownership by 2% to 86,282 units (SEC Form 4)

      4 - DIVERSIFIED HEALTHCARE TRUST (0001075415) (Issuer)

      11/14/24 4:15:49 PM ET
      $DHC
      Real Estate Investment Trusts
      Real Estate

    $DHC
    SEC Filings

    See more
    • Diversified Healthcare Trust filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - DIVERSIFIED HEALTHCARE TRUST (0001075415) (Filer)

      6/2/25 4:21:50 PM ET
      $DHC
      Real Estate Investment Trusts
      Real Estate
    • Diversified Healthcare Trust filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

      8-K - DIVERSIFIED HEALTHCARE TRUST (0001075415) (Filer)

      6/2/25 4:12:55 PM ET
      $DHC
      Real Estate Investment Trusts
      Real Estate
    • SEC Form S-8 filed by Diversified Healthcare Trust

      S-8 - DIVERSIFIED HEALTHCARE TRUST (0001075415) (Filer)

      5/29/25 4:38:02 PM ET
      $DHC
      Real Estate Investment Trusts
      Real Estate

    $DHC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Diversified Healthcare Trust

      SC 13G/A - DIVERSIFIED HEALTHCARE TRUST (0001075415) (Subject)

      11/8/24 5:20:29 PM ET
      $DHC
      Real Estate Investment Trusts
      Real Estate
    • Amendment: SEC Form SC 13D/A filed by Diversified Healthcare Trust

      SC 13D/A - DIVERSIFIED HEALTHCARE TRUST (0001075415) (Subject)

      10/9/24 8:53:11 PM ET
      $DHC
      Real Estate Investment Trusts
      Real Estate
    • SEC Form SC 13G filed by Diversified Healthcare Trust

      SC 13G - DIVERSIFIED HEALTHCARE TRUST (0001075415) (Subject)

      2/14/24 2:00:57 PM ET
      $DHC
      Real Estate Investment Trusts
      Real Estate